• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7-O-琥珀酰马氏菌素A三甲胺盐与替莫唑胺联合治疗实验性胶质母细胞瘤

Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma.

作者信息

Jin Jun, Hwang Kihwan, Joo Jin-Deok, Han Jung Ho, Kim Chae-Yong

机构信息

Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam-Si, Korea.

Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Oncotarget. 2017 Dec 14;9(2):2140-2147. doi: 10.18632/oncotarget.23295. eCollection 2018 Jan 5.

DOI:10.18632/oncotarget.23295
PMID:29416760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788628/
Abstract

7-O-succinyl macrolactin A has shown anti-inflammatory, anti-angiogenesis, and anti-metastatic effects. It also exhibits strong suppression of tumor growth. In our previous study, we assessed the anti-neoplastic effects of 7-O-succinyl macrolactin A tromethamine salt (SMA salt) on a glioma cell line. Moreover, according to our data, SMA salt might be contributed to the inhibitory effects on migration and invasion, as well as a cytotoxic effect on the glioblastoma cell lines. In the present study, we investigated the anti-tumor effects of combination therapy with SMA salt and temozolomide (TMZ) in glioblastoma cell lines. The combination therapy affected cell viability significantly, decreasing in glioblastoma cell lines. In cell migration assays, combination therapy showed more inhibitory effects than TMZ in these cell lines. The tumor volume was significantly decreased in the combination group compared with both TMZ and control groups by using the orthotopic mouse model. The effects of combination therapy with SMA salt and TMZ attributed to the inhibition of migration, invasion activities and anti-tumor effects. SMA salt could be one of the promising candidates for combination therapy in clinical settings.

摘要

7 - O - 琥珀酰大乳香素A已显示出抗炎、抗血管生成和抗转移作用。它还对肿瘤生长有强烈抑制作用。在我们之前的研究中,我们评估了7 - O - 琥珀酰大乳香素A三羟甲基氨基甲烷盐(SMA盐)对胶质瘤细胞系的抗肿瘤作用。此外,根据我们的数据,SMA盐可能对迁移和侵袭具有抑制作用,并对胶质母细胞瘤细胞系具有细胞毒性作用。在本研究中,我们研究了SMA盐与替莫唑胺(TMZ)联合治疗对胶质母细胞瘤细胞系的抗肿瘤作用。联合治疗显著影响细胞活力,使胶质母细胞瘤细胞系中的细胞活力降低。在细胞迁移试验中,联合治疗在这些细胞系中显示出比TMZ更强的抑制作用。通过原位小鼠模型,联合治疗组的肿瘤体积与TMZ组和对照组相比均显著减小。SMA盐与TMZ联合治疗的效果归因于对迁移、侵袭活性的抑制和抗肿瘤作用。SMA盐可能是临床联合治疗中有前景的候选药物之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/65a83847b8cb/oncotarget-09-2140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/2f4a11772118/oncotarget-09-2140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/c87f67190351/oncotarget-09-2140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/4d2953faff44/oncotarget-09-2140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/65a83847b8cb/oncotarget-09-2140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/2f4a11772118/oncotarget-09-2140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/c87f67190351/oncotarget-09-2140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/4d2953faff44/oncotarget-09-2140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f424/5788628/65a83847b8cb/oncotarget-09-2140-g004.jpg

相似文献

1
Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma.7-O-琥珀酰马氏菌素A三甲胺盐与替莫唑胺联合治疗实验性胶质母细胞瘤
Oncotarget. 2017 Dec 14;9(2):2140-2147. doi: 10.18632/oncotarget.23295. eCollection 2018 Jan 5.
2
Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model.7-O-琥珀酰马氏菌素A三羟甲基氨基甲烷盐在小鼠胶质瘤模型中的抗肿瘤活性
Oncol Lett. 2017 May;13(5):3767-3773. doi: 10.3892/ol.2017.5918. Epub 2017 Mar 27.
3
Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling.大环内酯素A及其琥珀酰衍生物的抗血管生成活性是通过抑制I类磷脂酰肌醇-3激酶(PI3K)活性及其信号传导来介导的。
Arch Pharm Res. 2015 Feb;38(2):249-60. doi: 10.1007/s12272-014-0535-x. Epub 2014 Dec 30.
4
The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.琥珀酰大内酯A的抗肿瘤活性通过抑制端锚聚合酶和PI3K/Akt,经由β-连环蛋白破坏复合体介导。
PLoS One. 2015 Nov 6;10(11):e0141753. doi: 10.1371/journal.pone.0141753. eCollection 2015.
5
Simultaneous determination of 7-O-succinyl macrolactin A and its metabolite macrolactin A in rat plasma using liquid chromatography coupled to tandem mass spectrometry.使用液相色谱-串联质谱法同时测定大鼠血浆中7-O-琥珀酰巨球型菌素A及其代谢产物巨球型菌素A
J Pharm Biomed Anal. 2014 Sep;98:85-9. doi: 10.1016/j.jpba.2014.05.009. Epub 2014 May 17.
6
Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.氨基酸正电子发射断层显像(PET)示踪剂是胶质母细胞瘤对包括替莫唑胺、干扰素-β和/或贝伐单抗在内的单药或联合治疗反应的可靠标志物。
Nucl Med Biol. 2015 Jul;42(7):598-607. doi: 10.1016/j.nucmedbio.2015.01.008. Epub 2015 Jan 31.
7
Antibacterial activities of macrolactin A and 7-O-succinyl macrolactin A from Bacillus polyfermenticus KJS-2 against vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.多黏菌素 A 和聚多黏菌素 KJS-2 中的 7-O-琥珀酰基多黏菌素 A 对万古霉素耐药肠球菌和耐甲氧西林金黄色葡萄球菌的抗菌活性。
Arch Pharm Res. 2011 Jan;34(1):147-52. doi: 10.1007/s12272-011-0117-0. Epub 2011 Apr 6.
8
NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.NVP-BEZ235,一种新型的双重 PI3K-mTOR 抑制剂,在人神经胶质瘤细胞中显示出抗神经胶质瘤活性,并降低替莫唑胺的化疗耐药性。
Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15.
9
Pharmacokinetics of macrolactin A and 7-O-succinyl macrolactin A in mice.小鼠中宏乳酸A和7 - O -琥珀酰宏乳酸A的药代动力学
Xenobiotica. 2014 Jun;44(6):547-54. doi: 10.3109/00498254.2013.861542. Epub 2013 Nov 26.
10
The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.孕酮与替莫唑胺联合使用对人胶质母细胞瘤细胞的协同作用。
PLoS One. 2015 Jun 25;10(6):e0131441. doi: 10.1371/journal.pone.0131441. eCollection 2015.

引用本文的文献

1
Macrolactins: biological activity and biosynthesis.大环内酯菌素:生物活性与生物合成
Mar Life Sci Technol. 2020 Oct 14;3(1):62-68. doi: 10.1007/s42995-020-00068-6. eCollection 2021 Feb.
2
The Combination PARP Inhibitor Olaparib With Temozolomide in an Experimental Glioblastoma Model.奥拉帕利联合替莫唑胺在实验性胶质母细胞瘤模型中的作用。
In Vivo. 2021 Jul-Aug;35(4):2015-2023. doi: 10.21873/invivo.12470.
3
The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations.

本文引用的文献

1
Current trends in mouse models of glioblastoma.胶质母细胞瘤小鼠模型的当前趋势。
J Neurooncol. 2017 Dec;135(3):423-432. doi: 10.1007/s11060-017-2626-2. Epub 2017 Oct 20.
2
How immunotherapies are targeting the glioblastoma immune environment.免疫疗法如何靶向胶质母细胞瘤的免疫环境。
J Clin Neurosci. 2018 Jan;47:20-27. doi: 10.1016/j.jocn.2017.10.019. Epub 2017 Oct 15.
3
Treatment of Glioblastoma.胶质母细胞瘤的治疗
OTS964与替莫唑胺联合使用对减小幂律编码的异质性胶质瘤干细胞群体大小的疗效。
Oncotarget. 2019 Mar 22;10(24):2397-2415. doi: 10.18632/oncotarget.26800.
4
Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo.纽卡斯尔病病毒增强替莫唑胺对体外和体内脑胶质瘤细胞的生长抑制和促凋亡作用。
Sci Rep. 2018 Jul 31;8(1):11470. doi: 10.1038/s41598-018-29929-y.
J Oncol Pract. 2017 Oct;13(10):629-638. doi: 10.1200/JOP.2017.025536.
4
Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model.7-O-琥珀酰马氏菌素A三羟甲基氨基甲烷盐在小鼠胶质瘤模型中的抗肿瘤活性
Oncol Lett. 2017 May;13(5):3767-3773. doi: 10.3892/ol.2017.5918. Epub 2017 Mar 27.
5
15α-methoxypuupehenol Induces Antitumor Effects and against Human Glioblastoma and Breast Cancer Models.15α-甲氧基普佩酚对人胶质母细胞瘤和乳腺癌模型具有抗肿瘤作用。
Mol Cancer Ther. 2017 Apr;16(4):601-613. doi: 10.1158/1535-7163.MCT-16-0291. Epub 2017 Jan 9.
6
Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.慢病毒介导的PPM1D基因沉默与替莫唑胺化疗联合应用通过细胞凋亡和细胞周期阻滞根除恶性胶质瘤。
Oncol Rep. 2016 Nov;36(5):2544-2552. doi: 10.3892/or.2016.5089. Epub 2016 Sep 14.
7
The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.琥珀酰大内酯A的抗肿瘤活性通过抑制端锚聚合酶和PI3K/Akt,经由β-连环蛋白破坏复合体介导。
PLoS One. 2015 Nov 6;10(11):e0141753. doi: 10.1371/journal.pone.0141753. eCollection 2015.
8
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.两种西仑吉肽方案联合标准治疗新诊断的胶质母细胞瘤且MGMT基因启动子未甲基化患者:开放标签、对照、随机II期CORE研究结果
Neuro Oncol. 2015 May;17(5):708-17. doi: 10.1093/neuonc/nou356. Epub 2015 Mar 11.
9
Mouse models of glioma.胶质瘤小鼠模型
J Clin Neurosci. 2015 Apr;22(4):619-26. doi: 10.1016/j.jocn.2014.10.013. Epub 2015 Feb 16.
10
Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling.大环内酯素A及其琥珀酰衍生物的抗血管生成活性是通过抑制I类磷脂酰肌醇-3激酶(PI3K)活性及其信号传导来介导的。
Arch Pharm Res. 2015 Feb;38(2):249-60. doi: 10.1007/s12272-014-0535-x. Epub 2014 Dec 30.